Indivior PLC Proposes Re-Domiciliation to Delaware

TradingView
2025.11.14 14:15
portai
I'm PortAI, I can summarize articles.

Indivior PLC announced plans to re-domicile from the U.K. to Delaware, U.S., establishing Indivior Pharmaceuticals, Inc. as the new holding company. This move aims to enhance U.S. capital market presence and simplify governance. Shareholders will vote on this proposal on December 11, 2025. If approved, Indivior Pharmaceuticals shares will replace Indivior shares on Nasdaq, aligning with the U.S.-based majority shareholder base.

On November 14, 2025, Indivior PLC announced a proposal to re-domicile from the U.K. to Delaware, U.S.

Key Highlights:

  • Indivior plans to establish Indivior Pharmaceuticals, Inc. as the new holding company.
  • The re-domiciliation aims to enhance U.S. capital market presence and simplify governance.
  • Shareholders will vote on the proposal at an Extraordinary General Meeting on December 11, 2025.
  • If approved, Indivior Pharmaceuticals shares will replace Indivior shares on Nasdaq.
  • The move aligns with the majority of Indivior's shareholder base being U.S.-based.

Original SEC Filing: INDIVIOR PLC [ INDV ] - 8-K - Nov. 14, 2025

Disclaimer
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.